主动脉内覆膜支架原位开窗术的综合综述
本文综述了原位开窗术(ISF)的适应证、技术描述和结果。通过PRISMA指南检索文献,最终纳入34篇。58例患者共尝试73次ISF,技术成功率为93%,30天死亡2例(3.4%),无ISF相关的主要并发症或内漏。结论认为短期结果满意但长期数据缺乏,ISF应仅限用于紧急挽救或研究。
要点
- ISF技术成功率高(93%),短期结果满意。
- 30天死亡率3.4%,无ISF相关的主要并发症或内漏。
- ISF应仅用于紧急挽救或研究性场景。
核心结论
- ISF短期结果满意,但长期数据缺乏,应仅限用于紧急挽救或研究。
研究设计与样本
- 遵循PRISMA指南的系统综述,检索Medline、Cochrane、Web of Science和Scopus,最终纳入34篇文献。
主要发现
- 58例患者共尝试73次ISF,其中26例(45%)为紧急情况,3例(5%)为挽救性。
- ISF技术成功率为68/73(93%)。
- 30天死亡2例(3.4%),分别与主动脉支气管瘘和主动脉食管瘘相关。
- 随访0-72个月,晚期死亡4例(6.9%),与主动脉无关;1例(1.7%)左锁骨下动脉支架狭窄无症状。
临床怎么用
- ISF目前为超说明书操作,不应在紧急挽救或研究性研究之外使用。
局限性
- 可能存在发表偏倚;长期数据缺乏。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Despite technical advances of fenestrated and branched endografts, endovascular exclusion of aneurysms involving renal, visceral, and/or supra-aortic branches remains a challenge. In situ fenestration (ISF) of standard endografts represents another endovascular means to maintain perfusion to such branches. This study aimed to review current indications, technical descriptions, and results of ISF. METHOD: A review of the English language literature was performed in Medline databases, Cochrane Database, Web of Science, and Scopus using the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines. Sixty-seven relevant papers were selected. Thirty-three papers were excluded, leaving 34 articles as the basis of the present review. RESULTS: Most experimental papers evaluated ISF feasibility and assessed the consequences of ISF on graft fabric. Regarding clinical papers, 73 ISF procedures have been attempted in 58 patients, including 26 (45%) emergent and three (5%) bailout cases. Sixty-five (89%) ISF were located at the level of the arch, and eight (11%) in the abdominal aorta. Graft perforation was performed by physical, mechanical, or unspecified means in 33 (45%), 38 (52%), and two vessels (3%), respectively. ISF was technically successful in 68/73 (93%) arteries. At 30 days, two (3.4%) patients died in the setting of an aorto-bronchial fistula and an aorto-oesophageal fistula, respectively. No post-operative death, major complication, or endoleak was described as secondary to the ISF procedure. With follow-up between 0 and 72 months, four (6.9%) late deaths were noted, unrelated to the aorta. One (1.7%) LSA stent was stenosed without symptoms. CONCLUSIONS: Although there may be publication bias, multiple techniques were described to perform ISF with satisfactory short-term results. Long-term data remain scarce. Aortic endograft ISF is an off-label procedure that should not be used outside emergent bailout techniques or investigational studies. A comparison with alternative techniques of preserving aortic side branches is needed.
引用
- Glorion M, Coscas R, McWilliams RG, et al. A Comprehensive Review of In Situ Fenestration of Aortic Endografts. Eur J Vasc Endovasc Surg. 2016. PMID: 27843111. doi:10.1016/j.ejvs.2016.10.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。